跳至主要内容
临床试验/NCT01061853
NCT01061853终止3 期

Efficacy of Topical Rapamycin in Treatment of Chronic Erosive Oral Lichen Planus. Double Blind Randomised Controlled Trial Rapamycin vs Topical Steroids

University Hospital, Tours9 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2008年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
76
试验地点
9
主要终点
COMPLETE CLEARING OF ORAL EROSIVE LESIONS

研究概览

简要总结

The purpose of this study is to determine wether topical rapamycin is more efficient than topical steroids in the treatment of chronic erosive lichen planus.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Oral Lichen Planus
  • Oral Erosive Area More Than 1cm²
  • Lichen Planus Pathologically Proven

排除标准

  • No Previous Treatment by Rapamycin
  • Non Child Bearing Or Breast Feeding Woman
  • Patient Who Cannot Be Treated By Rapamycin Or Betamethasone
  • Chronic Renal Insufficiency (Creatinin Clearance < 40ml/Mn)
  • Ongoing Treatment By Topical Calcineurin Inhibitors Or Systemic Steroids Or Retinoids Or Systemic Immunosuppressors Or Thalidomide Or Griseofulvin Or Antimalarials
  • Cholesterolemia >7.8 Mmol/L Or Hypertriglyceridemia >3.95mmol/L Non Responsive To Medical Treatments
  • Leucopenia (<3000/Mm3)
  • Thrombopenia (<100 000/Mm3)
  • Hypertransaminasemia (>3n)
  • Hypersensitivity To Macrolides

研究组 & 干预措施

T

Experimental

TOPICAL SIROLIMUS AND PETROLATUM IN ORABASE

干预措施: TOPICAL SIROLIMUS (RAPAMUNE*) (Drug)

C

Active Comparator

TOPICAL BETAMETHASONE 0.05% in ORABASE AND PHOSAL

干预措施: TOPICAL BETAMETHASONE 0.05% (Drug)

结局指标

主要结局

COMPLETE CLEARING OF ORAL EROSIVE LESIONS

时间窗: THREE MONTHS

次要结局

  • REGRESSION OF EROSIVE SURFACE AREA(THREE MONTHS)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验